PDB Short entry for 3PMH HEADER BLOOD CLOTING, HYDROLASE/INHIBITOR 16-NOV-10 3PMH TITLE MECHANISM OF SULFOTYROSINE-MEDIATED GLYCOPROTEIN IB INTERACTION WITH TITLE 2 TWO DISTINCT ALPHA-THROMBIN SITES COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN ALPHA-CHAIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: COAGULATION FACTOR II; COMPND 5 EC: 3.4.21.5; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: THROMBIN BETA-CHAIN; COMPND 8 CHAIN: B; COMPND 9 SYNONYM: COAGULATION FACTOR II; COMPND 10 EC: 3.4.21.5; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: PLATELET GLYCOPROTEIN IB ALPHA CHAIN; COMPND 13 CHAIN: G; COMPND 14 FRAGMENT: UNP RESIDUES 17-306; COMPND 15 ENGINEERED: YES; COMPND 16 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 OTHER_DETAILS: FROM HUMAN PLASMA; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 OTHER_DETAILS: FROM HUMAN PLASMA; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: GP1BA, PLATELET GLYCOPROTEIN IB ALPHA; SOURCE 16 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 7227 KEYWDS SULFATED TYROSINE RESIDUES, LEUCINE RICH REPEATS, PROTEASE PLATELET KEYWDS 2 RECEPTOR OF THROMBIN, THROMBIN BINDING, PLATELET SURFACE, BLOOD KEYWDS 3 CLOTING, HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.I.VARUGHESE,R.CELIKEL REVDAT 5 06-DEC-23 3PMH 1 REMARK REVDAT 4 06-SEP-23 3PMH 1 HETSYN REVDAT 3 29-JUL-20 3PMH 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 LINK SITE ATOM REVDAT 2 10-AUG-11 3PMH 1 JRNL VERSN REVDAT 1 01-JUN-11 3PMH 0 JRNL AUTH A.ZARPELLON,R.CELIKEL,J.R.ROBERTS,R.A.MCCLINTOCK, JRNL AUTH 2 G.L.MENDOLICCHIO,K.L.MOORE,H.JING,K.I.VARUGHESE,Z.M.RUGGERI JRNL TITL BINDING OF ALPHA-THROMBIN TO SURFACE-ANCHORED PLATELET JRNL TITL 2 GLYCOPROTEIN IB(ALPHA) SULFOTYROSINES THROUGH A TWO-SITE JRNL TITL 3 MECHANISM INVOLVING EXOSITE I. JRNL REF PROC.NATL.ACAD.SCI.USA V. 108 8628 2011 JRNL REFN ISSN 0027-8424 JRNL PMID 21555542 JRNL DOI 10.1073/PNAS.1017042108 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.2 REMARK 3 NUMBER OF REFLECTIONS : 12148 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : 5% REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 611 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4617 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 106 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3PMH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-DEC-10. REMARK 100 THE DEPOSITION ID IS D_1000062553. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 2005 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0332 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : DOUBLE CRYSTAL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12148 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.2 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 26.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.31 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.39700 REMARK 200 <I/SIGMA(I)> FOR SHELL : 7.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1OOK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG 6000, 0.2M AMMONIUM PHOSPHATE, REMARK 280 PH 7.0, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 164.86500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 33.82850 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 33.82850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 247.29750 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 33.82850 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 33.82850 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 82.43250 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 33.82850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 33.82850 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 247.29750 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 33.82850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 33.82850 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 82.43250 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 164.86500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, G, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU G 285 REMARK 465 GLY G 286 REMARK 465 ASP G 287 REMARK 465 LYS G 288 REMARK 465 VAL G 289 REMARK 465 ARG G 290 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 1E 116.85 93.82 REMARK 500 ALA A 1B -18.84 67.22 REMARK 500 PHE A 7 -93.19 -138.73 REMARK 500 LEU B 41 -62.16 -96.20 REMARK 500 ASP B 49 3.92 -65.81 REMARK 500 ARG B 50 5.16 -154.65 REMARK 500 HIS B 57 -5.24 -59.26 REMARK 500 TYR B 60A 75.01 -154.85 REMARK 500 ASP B 60E 58.05 20.81 REMARK 500 ASN B 60G 87.06 -160.81 REMARK 500 HIS B 71 -60.23 -122.71 REMARK 500 ARG B 77A -114.20 1.26 REMARK 500 ASN B 78 44.65 -99.38 REMARK 500 GLU B 97A -59.36 -127.90 REMARK 500 PRO G 2 -111.71 -54.07 REMARK 500 SER G 7 -158.49 -134.30 REMARK 500 LYS G 8 -151.27 -169.96 REMARK 500 VAL G 9 109.88 124.55 REMARK 500 ALA G 10 -143.31 86.09 REMARK 500 LYS G 19 46.03 39.83 REMARK 500 PRO G 26 101.41 -52.22 REMARK 500 ASP G 28 79.11 51.39 REMARK 500 PRO G 30 125.84 -37.28 REMARK 500 GLU G 40 35.32 36.50 REMARK 500 ASN G 41 -159.55 -99.75 REMARK 500 MET G 52 -49.58 -29.14 REMARK 500 PRO G 53 -145.08 -66.08 REMARK 500 TYR G 54 46.20 38.42 REMARK 500 THR G 55 0.66 -52.58 REMARK 500 GLU G 66 57.03 39.74 REMARK 500 ASP G 73 -88.00 -113.42 REMARK 500 PRO G 77 -16.73 -46.08 REMARK 500 ASN G 110 -146.84 -127.24 REMARK 500 PRO G 116 173.06 -54.76 REMARK 500 LEU G 123 37.57 -80.17 REMARK 500 GLU G 125 47.88 -105.63 REMARK 500 ASN G 134 -164.60 -103.30 REMARK 500 THR G 147 63.56 -116.29 REMARK 500 LEU G 171 54.29 22.62 REMARK 500 ASN G 182 -149.69 -116.09 REMARK 500 PRO G 188 170.60 -52.62 REMARK 500 LYS G 189 -96.20 -39.79 REMARK 500 ASN G 210 -137.25 -127.90 REMARK 500 GLN G 232 -176.12 175.18 REMARK 500 VAL G 234 -19.28 67.70 REMARK 500 VAL G 236 86.14 56.70 REMARK 500 LYS G 237 52.64 -60.93 REMARK 500 THR G 240 108.86 45.24 REMARK 500 ASN G 242 77.99 -171.82 REMARK 500 ASP G 252 -96.91 -24.60 REMARK 500 REMARK 500 THIS ENTRY HAS 60 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: D-PHENYLALANYL-N-[(3S)-6-CARBAMIMIDAMIDO-1-CHLORO-2- REMARK 630 OXOHEXAN-3-YL]-L-PROLINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0G7 B 301 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: DPN PRO ARG 0QE REMARK 630 DETAILS: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1OOK RELATED DB: PDB REMARK 900 SAME EXCEPT SULFATION OF RESIDUE Y278 (G CHAIN) DBREF 3PMH A 1H 15 UNP P00734 THRB_HUMAN 328 363 DBREF 3PMH B 16 247 UNP P00734 THRB_HUMAN 364 622 DBREF 3PMH G 1 290 UNP P07359 GP1BA_HUMAN 17 306 SEQADV 3PMH ALA G 65 UNP P07359 CYS 81 ENGINEERED MUTATION SEQRES 1 A 36 THR PHE GLY SER GLY GLU ALA ASP CYS GLY LEU ARG PRO SEQRES 2 A 36 LEU PHE GLU LYS LYS SER LEU GLU ASP LYS THR GLU ARG SEQRES 3 A 36 GLU LEU LEU GLU SER TYR ILE ASP GLY ARG SEQRES 1 B 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 B 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 B 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 B 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 B 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 B 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 B 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 B 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 B 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 B 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 B 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 B 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 B 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 B 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 B 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 B 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 B 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 B 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 B 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 B 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 G 290 HIS PRO ILE CYS GLU VAL SER LYS VAL ALA SER HIS LEU SEQRES 2 G 290 GLU VAL ASN CYS ASP LYS ARG ASN LEU THR ALA LEU PRO SEQRES 3 G 290 PRO ASP LEU PRO LYS ASP THR THR ILE LEU HIS LEU SER SEQRES 4 G 290 GLU ASN LEU LEU TYR THR PHE SER LEU ALA THR LEU MET SEQRES 5 G 290 PRO TYR THR ARG LEU THR GLN LEU ASN LEU ASP ARG ALA SEQRES 6 G 290 GLU LEU THR LYS LEU GLN VAL ASP GLY THR LEU PRO VAL SEQRES 7 G 290 LEU GLY THR LEU ASP LEU SER HIS ASN GLN LEU GLN SER SEQRES 8 G 290 LEU PRO LEU LEU GLY GLN THR LEU PRO ALA LEU THR VAL SEQRES 9 G 290 LEU ASP VAL SER PHE ASN ARG LEU THR SER LEU PRO LEU SEQRES 10 G 290 GLY ALA LEU ARG GLY LEU GLY GLU LEU GLN GLU LEU TYR SEQRES 11 G 290 LEU LYS GLY ASN GLU LEU LYS THR LEU PRO PRO GLY LEU SEQRES 12 G 290 LEU THR PRO THR PRO LYS LEU GLU LYS LEU SER LEU ALA SEQRES 13 G 290 ASN ASN ASN LEU THR GLU LEU PRO ALA GLY LEU LEU ASN SEQRES 14 G 290 GLY LEU GLU ASN LEU ASP THR LEU LEU LEU GLN GLU ASN SEQRES 15 G 290 SER LEU TYR THR ILE PRO LYS GLY PHE PHE GLY SER HIS SEQRES 16 G 290 LEU LEU PRO PHE ALA PHE LEU HIS GLY ASN PRO TRP LEU SEQRES 17 G 290 CYS ASN CYS GLU ILE LEU TYR PHE ARG ARG TRP LEU GLN SEQRES 18 G 290 ASP ASN ALA GLU ASN VAL TYR VAL TRP LYS GLN GLY VAL SEQRES 19 G 290 ASP VAL LYS ALA MET THR SER ASN VAL ALA SER VAL GLN SEQRES 20 G 290 CYS ASP ASN SER ASP LYS PHE PRO VAL TYR LYS TYR PRO SEQRES 21 G 290 GLY LYS GLY CYS PRO THR LEU GLY ASP GLU GLY ASP THR SEQRES 22 G 290 ASP LEU TYS ASP TYS TYS PRO GLU GLU ASP THR GLU GLY SEQRES 23 G 290 ASP LYS VAL ARG MODRES 3PMH ASN G 159 ASN GLYCOSYLATION SITE MODRES 3PMH TYS G 276 TYR O-SULFO-L-TYROSINE MODRES 3PMH TYS G 278 TYR O-SULFO-L-TYROSINE MODRES 3PMH TYS G 279 TYR O-SULFO-L-TYROSINE HET TYS G 276 16 HET TYS G 278 16 HET TYS G 279 16 HET NAG C 1 14 HET NAG C 2 14 HET MAN C 3 11 HET MAN C 4 11 HET MAN C 5 11 HET 0G7 B 301 31 HET NAG G 601 14 HETNAM TYS O-SULFO-L-TYROSINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM 0G7 D-PHENYLALANYL-N-[(3S)-6-CARBAMIMIDAMIDO-1-CHLORO-2- HETNAM 2 0G7 OXOHEXAN-3-YL]-L-PROLINAMIDE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN 0G7 D-PHE-PRO-ARG CHLOROMETHYLKETONE (PPACK) FORMUL 3 TYS 3(C9 H11 N O6 S) FORMUL 4 NAG 3(C8 H15 N O6) FORMUL 4 MAN 3(C6 H12 O6) FORMUL 5 0G7 C21 H31 CL N6 O3 HELIX 1 1 PHE A 7 SER A 11 5 5 HELIX 2 2 THR A 14B GLU A 14H 1 7 HELIX 3 3 SER A 14I ILE A 14K 5 3 HELIX 4 4 ALA B 55 CYS B 58 5 4 HELIX 5 5 PRO B 60B ASP B 60E 5 4 HELIX 6 6 THR B 60I ASN B 62 5 3 HELIX 7 7 ASP B 125 LEU B 130 1 9 HELIX 8 8 GLU B 164 ASP B 170 1 7 HELIX 9 9 LEU B 234 ASP B 243 1 10 HELIX 10 10 ALA G 49 MET G 52 5 4 HELIX 11 11 LEU G 214 ASN G 223 1 10 HELIX 12 12 ALA G 224 VAL G 227 5 4 HELIX 13 13 ASN G 242 VAL G 246 5 5 HELIX 14 14 GLN G 247 SER G 251 5 5 HELIX 15 15 PRO G 255 TYR G 259 5 5 SHEET 1 A 8 SER B 20 ASP B 21 0 SHEET 2 A 8 GLN B 156 VAL B 163 -1 O VAL B 157 N SER B 20 SHEET 3 A 8 MET B 180 ALA B 183 -1 O CYS B 182 N VAL B 163 SHEET 4 A 8 GLY B 226 HIS B 230 -1 O TYR B 228 N PHE B 181 SHEET 5 A 8 TRP B 207 TRP B 215 -1 N TRP B 215 O PHE B 227 SHEET 6 A 8 PRO B 198 LYS B 202 -1 N MET B 201 O TYR B 208 SHEET 7 A 8 LYS B 135 GLY B 140 -1 N ARG B 137 O VAL B 200 SHEET 8 A 8 GLN B 156 VAL B 163 -1 O VAL B 158 N VAL B 138 SHEET 1 B 7 GLN B 30 ARG B 35 0 SHEET 2 B 7 GLU B 39 SER B 48 -1 O GLU B 39 N ARG B 35 SHEET 3 B 7 TRP B 51 THR B 54 -1 O LEU B 53 N SER B 45 SHEET 4 B 7 ALA B 104 LEU B 108 -1 O MET B 106 N VAL B 52 SHEET 5 B 7 LYS B 81 ILE B 90 -1 N GLU B 86 O LYS B 107 SHEET 6 B 7 LEU B 64 ILE B 68 -1 N VAL B 66 O SER B 83 SHEET 7 B 7 GLN B 30 ARG B 35 -1 N MET B 32 O ARG B 67 SHEET 1 C 2 LEU B 60 TYR B 60A 0 SHEET 2 C 2 LYS B 60F ASN B 60G-1 O LYS B 60F N TYR B 60A SHEET 1 D10 GLU G 5 SER G 7 0 SHEET 2 D10 GLU G 14 ASN G 16 -1 O ASN G 16 N GLU G 5 SHEET 3 D10 ILE G 35 HIS G 37 1 O HIS G 37 N VAL G 15 SHEET 4 D10 GLN G 59 ASN G 61 1 O ASN G 61 N LEU G 36 SHEET 5 D10 THR G 81 ASP G 83 1 O ASP G 83 N LEU G 60 SHEET 6 D10 VAL G 104 ASP G 106 1 O ASP G 106 N LEU G 82 SHEET 7 D10 GLU G 128 TYR G 130 1 O TYR G 130 N LEU G 105 SHEET 8 D10 LYS G 152 SER G 154 1 O SER G 154 N LEU G 129 SHEET 9 D10 THR G 176 LEU G 178 1 O LEU G 178 N LEU G 153 SHEET 10 D10 PHE G 199 PHE G 201 1 O PHE G 199 N LEU G 177 SHEET 1 E 2 THR G 45 SER G 47 0 SHEET 2 E 2 LYS G 69 GLN G 71 1 O GLN G 71 N PHE G 46 SSBOND 1 CYS A 1 CYS B 122 1555 1555 2.04 SSBOND 2 CYS B 42 CYS B 58 1555 1555 2.03 SSBOND 3 CYS B 168 CYS B 182 1555 1555 2.03 SSBOND 4 CYS B 191 CYS B 220 1555 1555 2.03 SSBOND 5 CYS G 4 CYS G 17 1555 1555 2.04 SSBOND 6 CYS G 209 CYS G 248 1555 1555 2.03 SSBOND 7 CYS G 211 CYS G 264 1555 1555 2.03 LINK ND2 ASN B 60G C1 NAG C 1 1555 1555 1.46 LINK ND2 ASN G 159 C1 NAG G 601 1555 1555 1.44 LINK C TYS G 276 N ASP G 277 1555 1555 1.32 LINK C TYS G 279 N PRO G 280 1555 1555 1.35 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.39 LINK O4 NAG C 2 C1 MAN C 3 1555 1555 1.41 LINK O3 MAN C 3 C1 MAN C 4 1555 1555 1.41 LINK O6 MAN C 3 C1 MAN C 5 1555 1555 1.41 CISPEP 1 SER B 36A PRO B 37 0 -0.24 CRYST1 67.657 67.657 329.730 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014780 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014780 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003033 0.00000